The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol.
Lauren Johansen, Paul Liknaitzky, Maja Nedeljkovic, Lisa Mastin-Purcell, Greg Murray
Systematic Reviews May 5, 2022 DOI: 10.1186/s13643-022-01930-7 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Systematic review protocol Peer reviewed |
|---|---|
| Topics | Psychedelic-assisted therapy Depression |
| Keywords | Mental health treatment Depression research Clinical psychology |
| Citations | 9 |
| Key findings | The review will be the first to collate evidence on psychological processes of change in psychedelic therapy for depression, but the field is preliminary and likely to show heterogeneity and limited empirical research. |
Abstract
Background: There is currently renewed interest in the use of psychedelic therapy in the treatment of psychiatric disorders, including depression. The proposed systematic review will aim to identify, evaluate and summarise the psychological processes of change underlying psychedelic therapy for depression in the current literature and consider the implications these processes may have on the psychotherapy component of treatment.
Methods: Scopus, PsycINFO, PubMed and Web of Science databases will be searched using relevant terms. Studies will be included if they discuss the use of a classic psychedelic to treat depression symptomology in an adult population and report or propose psychological processes responsible for depression symptom change. Two authors will independently screen articles, complete quality assessment tools and conduct data extraction. Empirical and non-empirical research will be extracted and synthesised separately. A narrative synthesis approach will be used to report psychological processes identified in the literature.
Discussion: This systematic review will be the first to collate available evidence on the psychological processes associated with psychedelic therapy for depression. The preliminary nature of this research field is expected to result in the review having several limitations, namely heterogeneity between studies and the inclusion of limited empirical research. We intend for this review to present the current state of the literature, identify gaps and generate candidate variables that warrant further investigation. SYSTEMATIC REVIEW: PROSPERO CRD42020197202.
Comparable studies
Other systematic reviews and meta-analyses on depression, most cited first.
Citations in the library
Cited by 8
- Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions. Neuropsychiatric Disease and Treatment 2024
- The Psychedelic Renaissance: A Catholic Perspective. Linacre Q September 15, 2024
- What are set and setting: Reducing vagueness to improve research and clinical practice. Journal of Psychopharmacology May 26, 2025
- Decoupling of cortical activity from behavioral state following administration of the classic psychedelic DOI. Neuropharmacology October 1, 2024
- Psychopharmacology: Examine the Emerging Pharmaceutical Treatments for Mental Health Conditions and their Effectiveness Compared to Traditional Medication Journal of Sociology, Psychology & Religious Studies December 5, 2023
and 3 more in the library
Cites 56
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. The Lancet Psychiatry May 17, 2016
- Default Mode Network Activity and Connectivity in Psychopathology Annual Review of Clinical Psychology March 29, 2012
- Trial of Psilocybin versus Escitalopram for Depression New England Journal of Medicine April 14, 2021
and 51 more in the library